ABCL Stock Analysis: Buy, Sell, or Hold?
ABCL - AbCellera Biologics Inc. Common Shares
$11.88
0.75 (6.74%)
▲
5d:
-3.18%
30d:
-1.16%
90d:
+27.19%
HOLD
MODERATE Confidence
Analysis Updated: Nov 6, 2026 12:00 AM ET
Earnings: Nov 09, 2026
0d
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Nov 4, 2026 at $12.20 · last confirmed Nov 4, 2026
Strength: 6.3/10
Get Alerted When ABCL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ABCL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ABCL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ABCL is currently trading at $11.88, which is considered slightly low relative to its 30-day fair value range of $11.69 to $13.58.
Technical Outlook: Technically, ABCL is in a strong uptrend. Immediate support is located at $10.76, while resistance sits at $13.86. The stock is showing strong short-term momentum, up 6.7% recently.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $17.17 (+44.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ABCL is in a strong uptrend. Immediate support is located at $10.76, while resistance sits at $13.86. The stock is showing strong short-term momentum, up 6.7% recently.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $17.17 (+44.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$11.69 -
$13.58
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (52/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.7%)
- BULLISH: Trading 44.5% below Wall St target ($17.17)
- NEUTRAL: Bottoming setup forming (52/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$11.69 -
$13.58
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$10.76
Resistance Level
$13.86
Current Trend
Strong Uptrend
Technical data as of
Nov 6, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-15.58
Wall Street Target
$17.17
(+44.5%)
Revenue Growth (YoY)
-76.3%
Earnings Growth (YoY)
45.9%
Profit Margin
-248.8%
Share ABCL Analysis
Share this live ABCL analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ABCL)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 7, 2026
Daily AI digest
AI Retail Discussion Summary:
Investors are bullish on $ABCL with excitement surrounding upcoming catalyst events, despite concerns over the stock's current book value premium relative to industry averages.
Key Retail Themes:
Bullish sentiment towards $ABCL
Upcoming catalyst events
Book value premium compared to industry averages
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 09, 2026 3:28 AM ET
Data refreshes hourly during market hours. Next update: 4:28 AM
Data refreshes hourly during market hours. Next update: 4:28 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABCL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$91 | 58 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 46 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 56 HOLD |
|
RAPP
Rapport Therapeutics, In… |
STRONG BUY
16 analysts |
$64 | 54 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$107 | 36 SELL |
More Analysis for ABCL
ABCL Technical Chart
ABCL Price Prediction
ABCL Earnings Date
Why is ABCL Moving Today?
ABCL Investment Advisor
ABCL Fair Price Analyzer
ABCL Competitors
ABCL DCF Intrinsic Value
Stock Sector Rotation Tracker
AI & Semi Supply Chain Money Flow
Live Gamma Exposure (GEX) Scanner
Reddit & WSB Sentiment Tracker
Backtested Stock Scanner
